These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1957561)

  • 1. Hormonal effects of apomorphine and cholecystokinin in pigs: modification of the response to cholecystokinin by a dopamine antagonist (metoclopramide) and a kappa opioid agonist (PD117302).
    Parrott RF; Ebenezer IS; Baldwin BA; Forsling ML
    Acta Endocrinol (Copenh); 1991 Oct; 125(4):420-6. PubMed ID: 1957561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCK-A receptors mediate the effect of cholecystokinin on vasopressin but not on cortisol in pigs.
    Parrott RF; Forsling ML
    Am J Physiol; 1992 Jun; 262(6 Pt 2):R1154-7. PubMed ID: 1621871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CCKA receptor antagonist devazepide inhibits the effect of apomorphine on vasopressin release in pigs.
    Parrott RF; Forsling ML
    Gen Pharmacol; 1994 Nov; 25(7):1337-40. PubMed ID: 7896043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central and peripheral doses of cholecystokinin that inhibit feeding in pigs also stimulate vasopressin and cortisol release.
    Parrott RF; Ebenezer IS; Baldwin BA; Forsling ML
    Exp Physiol; 1991 Jul; 76(4):525-31. PubMed ID: 1910760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of intravenous administration of cholecystokinin on feeding behaviour and release of pituitary hormones in pigs are not mediated by serotonergic (5-HT3) receptors.
    Parrott RF; Ebenezer IS; Forsling ML
    Neuropharmacology; 1992 Sep; 31(9):863-7. PubMed ID: 1436393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the novel cholecystokinin analogue Suc-Trp-N(Me)-Nle-Asp-Phe-NH2 on feeding and cortisol release in pigs.
    Ebenezer IS; Parrott RF; Goode JA
    Pharmacol Biochem Behav; 1996 May; 54(1):255-9. PubMed ID: 8728566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that opioid peptides and dopamine participate in the suckling-induced release of prolactin in the ewe.
    Knight PG; Howles CM; Cunningham FJ
    Neuroendocrinology; 1986; 44(1):29-35. PubMed ID: 3097561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between the effect of cholecystokinin octapeptide and apomorphine on ingestion of intraorally administered sucrose in male rats.
    Bednar I; Qureshi GA; Södersten P
    J Neuroendocrinol; 1992 Dec; 4(6):727-34. PubMed ID: 21554660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A central site of action for benzamide facilitation of gastric emptying.
    Costall B; Gunning SJ; Naylor RJ; Simpson KH
    Eur J Pharmacol; 1983 Jul; 91(2-3):197-205. PubMed ID: 6617741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betamethasone does not prevent nausea and vomiting induced by the dopamine-agonist apomorphine.
    Axelsson P; Thörn SE; Lövqvist A; Wattwil L; Wattwil M
    Can J Anaesth; 2006 Apr; 53(4):370-4. PubMed ID: 16575035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pizotifen, a serotonin antagonist, and of pirenzepine, a muscarinic antagonist, on hormonal responses to metoclopramide in healthy subjects.
    Jungmann E; Althoff PH; Hermann GJ; Schöffling K
    Arzneimittelforschung; 1984; 34(9):1022-4. PubMed ID: 6391497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the responses to some dopamine-receptor agonists and antagonists in the isolated perfused rat kidney.
    Woodman OL; Rechtman MP; Lang WJ
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):203-11. PubMed ID: 6971630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between metoclopramide and dopaminergic agonists at the level of sympathetic ganglion.
    Tuncer M
    Arch Int Physiol Biochim; 1984 Oct; 92(3):227-31. PubMed ID: 6084487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of apomorphine and haloperidol on plasma cortisol levels in conscious dogs.
    Uvnäs-Wallensten K; Goiny M; Oriowo MA; Cekan S
    Acta Physiol Scand; 1981 Jul; 112(3):253-6. PubMed ID: 7293796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of metoclopramide, domperidone and apomorphine on GH secretion in children and adolescents.
    Massara F; Tangolo D; Godano A; Goffi S; Bertagna A; Molinatti GM
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):451-5. PubMed ID: 3993312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoclopramide decreases apomorphine-induced yawning and penile erection.
    Heaton JP; Varrin SJ
    Pharmacol Biochem Behav; 1991 Apr; 38(4):917-20. PubMed ID: 1871205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
    Meltzer LT; Christoffersen CL; Serpa KA; Razmpour A
    Synapse; 1993 Feb; 13(2):117-22. PubMed ID: 8446920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin facilitates ejaculation in male rats: blockade with proglumide and apomorphine.
    Pfaus JG; Phillips AG
    Eur J Pharmacol; 1987 Sep; 141(3):331-8. PubMed ID: 3666030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intra-amygdalar dopamine agonists and antagonists on gastric stress lesions in rats.
    Ray A; Henke PG; Sullivan RM
    Neurosci Lett; 1988 Feb; 84(3):302-6. PubMed ID: 3352956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD117302: a selective agonist for the kappa-opioid receptor.
    Clark CR; Birchmore B; Sharif NA; Hunter JC; Hill RG; Hughes J
    Br J Pharmacol; 1988 Mar; 93(3):618-26. PubMed ID: 2836012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.